Best practices in designing preapproval information engagements for US health care decision makers

As high-cost and innovative therapies continue to enter the market, health care decision makers (HCDMs) are expressing a need for early information on a product’s clinical and economic impacts. Preapproval information exchange (PIE) fulfills these data needs by allowing manufacturers to share drug i...

Descripción completa

Detalles Bibliográficos
Autores principales: Dodda, Sai, Bannister, Breyanne, Hydery, Tasmina, Gorey, Claire, Dunlap, Sarah, Mody, Lorie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2023
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387941/
https://www.ncbi.nlm.nih.gov/pubmed/36840953
http://dx.doi.org/10.18553/jmcp.2023.29.3.245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387941/
https://www.ncbi.nlm.nih.gov/pubmed/36840953
http://dx.doi.org/10.18553/jmcp.2023.29.3.245

Ejemplares similares